Suggestions
Jared Kehe
Cofounder & CSO at Concerto Biosciences - - PhD in Biological Engineering, MIT
Jared Kehe is the Cofounder and Chief Scientific Officer (CSO) at Concerto Biosciences, a biotechnology company focused on microbial ecology and microbiome science.12 Here are some key details about Jared Kehe:
Background and Education
Jared holds a PhD in Biological Engineering from MIT, where he was an NSF Graduate Fellow and Presidential Fellow.2 He completed his Bachelor of Science in Bioengineering at the University of California, San Diego, graduating summa cum laude.2
Professional Experience
Concerto Biosciences: As Cofounder and CSO since June 2020, Jared oversees all product discovery and ongoing technological development at Concerto Biosciences.23 He is an original inventor of the company's platform technology called kChip.3
Research Contributions: Prior to Concerto, Jared was a Graduate Researcher at MIT's Blainey Lab from 2015 to 2020.2 His research focused on:
- Developing technologies for high-throughput combinatorial screening in microbiology
- Constructing massively parallel microbial communities for empirical discovery
- Conducting combinatorial antibiotics screening for novel drug synergies
Scientific Approach
Jared's work is inspired by classical music, which informs his perspective on microbiology.1 He views the microbial world as a huge musical performance, with microbes interacting like instruments in an orchestra.1 This analogy drives Concerto Biosciences' approach to studying microbial interactions and developing microbe-based products for human benefit.14
Technology Innovation
The kChip technology, co-invented by Jared, allows for the construction and monitoring of millions of miniature, defined microbial communities simultaneously.13 This innovation enables Concerto Biosciences to rapidly identify promising microbes, prebiotics, and metabolites for product development.34
Jared Kehe's expertise in microbial ecology, microbiome science, and microfluidics, combined with his innovative approach, positions him as a key figure in advancing the field of microbiome research and its applications in biotechnology and healthcare.34